HPV

History of Vaccines Blog


Lasker Prizer Goes to HPV Vaccine Developers

September 12, 2017

Lowy and Schiller, both wearing white coats, in laboratory
Lowy, left, and Schiller. Courtesy National Cancer Institute.

Only Two Doses of HPV Vaccine Needed for Younger Adolescents

October 20, 2016

Human papillomavirus vaccination series completion will now require only two doses of vaccine for adolescents younger than 15 years. The Advisory Committee on Immunization Practices approved this recommendation at their biannual meeting in Atlanta yesterday. The new schedule for <15 year olds calls for the second dose to be given between 6 and 12 months after the first dose. Adolescents receiving the first dose of HPV vaccine at age 15 or older will continue to be recommended three doses of vaccine, given at 0, 1-2, and 6 months.

Availability and Impact of 9-Valent HPV Vaccine

May 12, 2015

In late 2014, the US Food and Drug Administration approved a 9-valent human papillomavirus vaccine. In early 2015, the Advisory Committee on Immunization Practices made the recommendation that it be offered as one of the available HPV vaccines this country. The vaccine, made by Merck, is known commercially as Gardasil 9 and generically as Human Papillomavirus 9-valent Vaccine, Recombinant (9vHPV).

Helen Rees on HPV Vaccine Introduction in South Africa

October 20, 2014

Helen Rees, MD, MA. Courtesy WHOA few weeks ago, I attended a talk by the CDC's Anne Schuchat, MD, on US HPV vaccination that she subtitled “How Not to Introduce a Vaccine.” In spite of the promise of HPV vaccines to reduce the burden of cervical and other cancers in this country, uptake of the complete three-dose series has lagged far behind the other vaccines on the adolescent immunization platform.

Everything Has Changed: A Post for Cervical Health Awareness Month

January 7, 2014

Courtesy nccc-online.orgJanuary is National Cervical Health Awareness Month, sponsored by the National Cervical Cancer Coalition. My friend Izumi Kajimoto writes today's post.